DermaRite Industries recalled 6,973 cartridges of KleenFoam Antimicrobial Foam Soap on July 17, 2025. The product contains a harmful bacterial contamination, Burkholderia cepacia. Consumers should stop using the soap immediately and seek guidance from healthcare providers.
Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.
Consumers and healthcare providers should stop using this product immediately. Contact DermaRite Industries, LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recall involves KleenFoam Antimicrobial Foam Soap with Aloe Vera, 34 FL OZ (1000 mL) per cartridge. Lot numbers include 30705A, 30771A, 30920A, and several others with varying expiration dates from August 2025 to January 2027. The product was distributed nationwide in the USA.
KleenFoam soap has been found to be contaminated with Burkholderia cepacia, a bacterium that can pose serious health risks, especially to individuals with weakened immune systems or underlying health conditions. The contamination classifies this recall as Class I, indicating a high level of risk.
As of the recall date, there are no reported injuries associated with the contaminated soap. However, the potential health risks warrant immediate action.
Consumers should stop using the affected soap immediately and contact their healthcare provider for advice. DermaRite Industries will notify affected consumers by letter.
To report issues or seek further information, contact DermaRite Industries at 1-800-XXX-XXXX or visit their website.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.